210 related articles for article (PubMed ID: 15390186)
21. High DNA damage by benzo[a]pyrene 7,8-diol-9,10-epoxide in bronchial epithelial cells from patients with lung cancer: comparison with lung parenchyma.
Rojas M; Marie B; Vignaud JM; Martinet N; Siat J; Grosdidier G; Cascorbi I; Alexandrov K
Cancer Lett; 2004 Apr; 207(2):157-63. PubMed ID: 15072824
[TBL] [Abstract][Full Text] [Related]
22. Benzo[a]pyrene diol epoxide and bleomycin sensitivity and susceptibility to cancer of upper aerodigestive tract.
Wu X; Gu J; Hong WK; Lee JJ; Amos CI; Jiang H; Winn RJ; Fu KK; Cooper J; Spitz MR
J Natl Cancer Inst; 1998 Sep; 90(18):1393-9. PubMed ID: 9747870
[TBL] [Abstract][Full Text] [Related]
23. Removal of benzo(a)pyrene diol epoxide (BPDE)-DNA adducts as a measure of DNA repair capacity in lymphoblastoid cell lines from sisters discordant for breast cancer.
Motykiewicz G; Faraglia B; Wang LW; Terry MB; Senie RT; Santella RM
Environ Mol Mutagen; 2002; 40(2):93-100. PubMed ID: 12203401
[TBL] [Abstract][Full Text] [Related]
24. Effects of cadmium(II) on (+/-)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide-induced DNA damage response in human fibroblasts and DNA repair: a possible mechanism of cadmium's cogenotoxicity.
Mukherjee JJ; Gupta SK; Kumar S; Sikka HC
Chem Res Toxicol; 2004 Mar; 17(3):287-93. PubMed ID: 15025498
[TBL] [Abstract][Full Text] [Related]
25. 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology.
Kawauchi S; Sakai H; Ikemoto K; Eguchi S; Nakao M; Takihara H; Shimabukuro T; Furuya T; Oga A; Matsuyama H; Takahashi M; Sasaki K
Hum Pathol; 2009 Dec; 40(12):1783-9. PubMed ID: 19733894
[TBL] [Abstract][Full Text] [Related]
26. In vitro benzo[a]pyrene diol epoxide-induced DNA adducts and risk of squamous cell carcinoma of head and neck.
Li D; Wang LE; Chang P; El-Naggar AK; Sturgis EM; Wei Q
Cancer Res; 2007 Jun; 67(12):5628-34. PubMed ID: 17575128
[TBL] [Abstract][Full Text] [Related]
27. Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients.
Obermann EC; Meyer S; Hellge D; Zaak D; Filbeck T; Stoehr R; Hofstaedter F; Hartmann A; Knuechel R
Oncol Rep; 2004 Apr; 11(4):745-51. PubMed ID: 15010867
[TBL] [Abstract][Full Text] [Related]
28. Sensitivity to DNA-damage induction and chromosomal alterations in mucosa cells from patients with and without cancer of the oropharynx detected by a combination of Comet assay and fluorescence in situ hybridization.
Harréus UA; Kleinsasser NH; Zieger S; Wallner B; Reiter M; Schuller P; Berghaus A
Mutat Res; 2004 Oct; 563(2):131-8. PubMed ID: 15364279
[TBL] [Abstract][Full Text] [Related]
29. DNA repair capacity of lymphoblastoid cell lines from sisters discordant for breast cancer.
Kennedy DO; Agrawal M; Shen J; Terry MB; Zhang FF; Senie RT; Motykiewicz G; Santella RM
J Natl Cancer Inst; 2005 Jan; 97(2):127-32. PubMed ID: 15657342
[TBL] [Abstract][Full Text] [Related]
30. Serum antibodies to benzo(a)pyrene diol epoxide-DNA adducts in the general population: effects of air pollution, tobacco smoking, and family history of lung diseases.
Petruzzelli S; Celi A; Pulerà N; Baliva F; Viegi G; Carrozzi L; Ciacchini G; Bottai M; Di Pede F; Paoletti P; Giuntini C
Cancer Res; 1998 Sep; 58(18):4122-6. PubMed ID: 9751623
[TBL] [Abstract][Full Text] [Related]
31. Characterization of 9p21 copy number alterations in human melanoma by fluorescence in situ hybridization.
Rákosy Z; Vízkeleti L; Ecsedi S; Bégány A; Emri G; Adány R; Balázs M
Cancer Genet Cytogenet; 2008 Apr; 182(2):116-21. PubMed ID: 18406873
[TBL] [Abstract][Full Text] [Related]
32. Gene expression profiles and genetic damage in benzo(a)pyrene diol epoxide-exposed TK6 cells.
Akerman GS; Rosenzweig BA; Domon OE; McGarrity LJ; Blankenship LR; Tsai CA; Culp SJ; MacGregor JT; Sistare FD; Chen JJ; Morris SM
Mutat Res; 2004 May; 549(1-2):43-64. PubMed ID: 15120962
[TBL] [Abstract][Full Text] [Related]
33. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer.
Broberg K; Björk J; Paulsson K; Höglund M; Albin M
Carcinogenesis; 2005 Jul; 26(7):1263-71. PubMed ID: 15746160
[TBL] [Abstract][Full Text] [Related]
34. Expression of human glutathione S-transferase P1 confers resistance to benzo[a]pyrene or benzo[a]pyrene-7,8-dihydrodiol mutagenesis, macromolecular alkylation and formation of stable N2-Gua-BPDE adducts in stably transfected V79MZ cells co-expressing hCYP1A1.
Kushman ME; Kabler SL; Fleming MH; Ravoori S; Gupta RC; Doehmer J; Morrow CS; Townsend AJ
Carcinogenesis; 2007 Jan; 28(1):207-14. PubMed ID: 16885195
[TBL] [Abstract][Full Text] [Related]
35. Loss of P16 expression and chromosome 9p21 LOH in predicting outcome of patients affected by superficial bladder cancer.
Bartoletti R; Cai T; Nesi G; Roberta Girardi L; Baroni G; Dal Canto M
J Surg Res; 2007 Dec; 143(2):422-7. PubMed ID: 17612565
[TBL] [Abstract][Full Text] [Related]
36. Arsenite enhances the benzo[a]pyrene diol epoxide (BPDE)-induced mutagenesis with no marked effect on repair of BPDE-DNA adducts in human lung cells.
Chiang HC; Tsou TC
Toxicol In Vitro; 2009 Aug; 23(5):897-905. PubMed ID: 19470404
[TBL] [Abstract][Full Text] [Related]
37. Induction of centrosome amplification and chromosome instability in p53-deficient lung cancer cells exposed to benzo[a]pyrene diol epoxide (B[a]PDE).
Shinmura K; Iwaizumi M; Igarashi H; Nagura K; Yamada H; Suzuki M; Fukasawa K; Sugimura H
J Pathol; 2008 Nov; 216(3):365-74. PubMed ID: 18788085
[TBL] [Abstract][Full Text] [Related]
38. [Smoking, the level of DNA adducts and chronic obstructive pulmonary diseases].
Xie JG; Xu YJ; Zhang ZX; Ni W; Chen SX
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):469-73. PubMed ID: 15312561
[TBL] [Abstract][Full Text] [Related]
39. Benzo[a]pyrene diol epoxide up-regulates COX-2 expression through NF-kappaB in rat astrocytes.
Weng MW; Hsiao YM; Chen CJ; Wang JP; Chen WC; Ko JL
Toxicol Lett; 2004 Jul; 151(2):345-55. PubMed ID: 15183459
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of homozygous deletions and multiple duplications at the CDKN2A (p16INK4a)/ARF (p14ARF) locus in urinary bladder cancer.
Berggren de Verdier PJ; Kumar R; Adolfsson J; Larsson P; Norming U; Onelöv E; Wijkström H; Steineck G; Hemminki K
Scand J Urol Nephrol; 2006; 40(5):363-9. PubMed ID: 17060081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
